ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,761.00
0.77%
S&P ASX All Technology
3,066.90
-0.26%
Brent Oil
81.025
0.27%
US Dollar vs AUD
1.5055
0.46%
Bitcoin
69,134.14
2.05%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Plus Therapeutics Inc (PSTV)

  7. Plus Therapeutics Inc (PSTV) News

PSTV Plus Therapeutics Inc

2.21
0.00 (0.00%)
Pre Market
Last Updated: 18:01:48
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Plus Therapeutics Inc PSTV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 2.21 18:01:48
Open Price Low Price High Price Close Price Previous Close
2.21
more quote information »

Recent News

Date Time Source Heading
20/5/202421:00EDGAR2Form 8-K - Current report
18/5/202407:00GLOBEPlus Therapeutics Announces New Employment Inducement Grants
16/5/202406:15GLOBEPlus Therapeutics Reports First Quarter 2024 Financial..
16/5/202406:01EDGAR2Form 8-K - Current report
16/5/202406:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202421:30GLOBEPlus Therapeutics to Announce First Quarter Financial..
10/5/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202407:20EDGAR2Form 8-K - Current report
10/5/202401:29GLOBEPlus Therapeutics Provides Highlights Regarding..
09/5/202407:35GLOBEPlus Therapeutics to Host Investor Call to Discuss..
06/5/202421:30GLOBEPlus Therapeutics Announces Private Placement Financing of..
22/4/202421:00GLOBEPlus Therapeutics Receives $3 Million Award Recommendation..
09/3/202408:30EDGAR2Form S-1/A - General form for registration of securities..
06/3/202408:04EDGAR2Form 8-K - Current report
06/3/202408:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202410:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202309:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202308:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/11/202308:08EDGAR2Form S-1 - General form for registration of securities under..
21/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
20/11/202323:01EDGAR2Form 8-K - Current report
17/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:55EDGAR2Form 8-K - Current report
01/11/202307:06EDGAR2Form 8-K - Current report
01/11/202307:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/9/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202321:00GLOBEPlus Therapeutics Receives $1.9 Million Advance Payment from..
08/9/202321:00GLOBEPlus Therapeutics Enters into License Agreement for..
05/9/202321:00GLOBEPlus Therapeutics Initiates Part B of ReSPECT-LM Phase 1/2a..
30/8/202321:00GLOBEPlus Therapeutics to Present at the H.C. Wainwright 25th..
21/8/202320:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202306:12EDGAR2Form 8-K - Current report
15/8/202306:05GLOBEPlus Therapeutics Reports Second Quarter 2023 Financial..
15/8/202306:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

NASDAQ
PSTV
Plus Therapeutics
LSE
CWK
Cranswick
EU
SOI
SOITEC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved